Sofosbuvir-Based Treatment Regimens for Chronic, Genotype 1 Hepatitis C Virus Infection in U.S. Incarcerated Populations-Reference-Cited by-同舟云学术

Sofosbuvir-Based Treatment Regimens for Chronic, Genotype 1 Hepatitis C Virus Infection in U.S. Incarcerated Populations

Published:2014-10-21 Issue:8 Volume:161 Page:546
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Liu Shan¹,Watcha Daena¹,Holodniy Mark¹,Goldhaber-Fiebert Jeremy D.¹

Affiliation:

1. From University of Washington, Seattle, Washington; UCSF School of Medicine, San Francisco, California; Veterans Affairs Palo Alto Health Care System, Palo Alto, California; and Stanford University School of Medicine and Stanford University, Stanford, California.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus micro‐elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide;The Kaohsiung Journal of Medical Sciences;2023-11-27

2. HCV Microelimination for High-risk Special Populations;The Journal of Infectious Diseases;2023-09-13

3. Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection;Clinical Infectious Diseases;2023-05-25

4. Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs;American Journal of Preventive Medicine;2023-01

5. Economic burden of chronic viral hepatitis C;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2022-01-15